Brian T. Powl Fate Therapeutics Inc (FATE) insider trading activity

FATE Quotes by TradingView

Brian T. Powl is Chief Commercial Officer of FATE THERAPEUTICS INC. Currently has a direct ownership of 41,146 shares of FATE, which is worth approximately $69,125. The most recent transaction as insider was on Jul 05, 2023, when has been sold 3,854 shares (Common Stock) at a price of $4.87 per share, resulting in proceeds of $18,768. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.1K
0% 3M change
0% 12M change
Total Value Held $69,125

Brian T. Powl Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 05 2023
SELL
Open market or private sale
$18,768 $4.87 p/Share
3,854 Reduced 8.56%
41,146 Common Stock
Jun 27 2022
BUY
Grant, award, or other acquisition
-
45,000 Added 50.0%
45,000 Common Stock

Also insider at

KURA
Kura Oncology, Inc. Healthcare
Chief Commercial Officer
BTP

Brian T. Powl

Chief Commercial Officer
San Diego, CA

Track Institutional and Insider Activities on FATE

Follow FATE THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FATE shares.

Notify only if

Insider Trading

Get notified when an Fate Therapeutics Inc insider buys or sells FATE shares.

Notify only if

News

Receive news related to FATE THERAPEUTICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FATE